[PS1-9-5] The efficacy and safety of combination of Hyper-CVAD with ponatinib for patients with Ph+ALL
Abstract password authentication.
Password is written on a program and abstract book.
Poster Session
Fri. Oct, 12
Fri. Oct 12, 2018 5:30 PM - 6:10 PM Poster1 (Osaka International Convention Center, 3F Event Hall)
Chair: Isamu Sugiura (Toyohashi Municipal Hospital Division of Hematology and Oncology)
Abstract password authentication.
Password is written on a program and abstract book.